Ben Tre Pharmaceutical appointed 24-year-old Tran Ngo Minh Anh as general director. The appointment was based on a decision dated 23 October and took effect on 1 November.
Ben Tre Pharmaceutical Joint Stock Company (Bepharco, DBT) announced a change in its management team and appointed Tran Ngo Minh Anh as general director. The appointment was based on a decision dated 23 October and took effect on 1 November.
Minh Anh was born in 2002 and is the daughter of Tran Ngo Phuc Vu, chairman of Nam A Bank. She majored in finance at the University of Central Florida in the US and worked for New Yom Bank (NOB) after graduating. She later returned to Vietnam, was elected as a director at the extraordinary general meeting of shareholders held this year, and became general director after serving as deputy general director.
Ben Tre Pharmaceutical was established in 1963 and changed its name to Bepharco following its privatisation in 2004. It has VDN 20 billion in capital, with the state holding 51%. The company listed on the Hanoi Stock Exchange as DBT in 2009, completing the sale of the government’s stake after reducing it to 34% by the end of 2014. It listed on HoSE in 2020. In the first half of 2025, net revenue was approximately VDN 417.5 billion and profit after tax approximately VDN 25 billion, representing revenue growth of more than 3% year on year. According to the company, the increase was mainly attributable to proceeds from the transfer of 3.7 million shares in Codupha Central Pharmaceutical. Total assets were approximately VDN 881.6 billion, liabilities approximately VDN 585 billion and equity approximately VDN 296.5 billion.